Chen Chen
Stock Analyst at UBS
(4.54)
# 1,022
Out of 5,014 analysts
46
Total ratings
62.1%
Success rate
39.6%
Average return
Main Sectors:
Stocks Rated by Chen Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $149.00 | $108.70 | +37.07% | 8 | Sep 14, 2026 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $51.10 → $62.00 | $56.05 | +10.62% | 5 | Sep 1, 2026 | |
| HKG: 3759 Pharmaron Beijing Co., Ltd. | Downgraded: Hold | $35.30 | $31.82 | +10.94% | 1 | Aug 25, 2026 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Reiterated: Hold | $34.70 | $19.30 | +79.79% | 4 | Mar 13, 2026 | |
| HKG: 9969 InnoCare Pharma Limited | Reiterated: Buy | $23.60 | $14.79 | +59.57% | 5 | Dec 14, 2025 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Hold | $63.80 | $77.10 | -17.25% | 6 | Dec 9, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Buy | $50.00 → $56.30 | $46.88 | n/a | 4 | Sep 1, 2025 | |
| HKG: 6127 Joinn Laboratories(China)Co.,Ltd. | Reiterated: Hold | $14.30 → $16.30 | $30.80 | n/a | 5 | Jul 14, 2025 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Upgraded: Buy | $40.10 → $70.40 | $215.20 | n/a | 2 | Nov 1, 2024 | |
| HKG: 2252 Shanghai MicroPort MedBot (Group) Co., Ltd. | Reiterated: Buy | $20.00 → $9.50 | $21.18 | n/a | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35.70 | $23.00 | n/a | 1 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $365.94 | n/a | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $123.10 | $487.00 | n/a | 1 | Nov 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | 223p | 748p | n/a | 1 | Aug 30, 2021 |
Akeso, Inc.
Sep 14, 2026
Reiterated: Buy
Price Target: $149.00
Current: $108.70
Upside: +37.07%
WuXi Biologics (Cayman) Inc.
Sep 1, 2026
Reiterated: Buy
Price Target: $51.10 → $62.00
Current: $56.05
Upside: +10.62%
Pharmaron Beijing Co., Ltd.
Aug 25, 2026
Downgraded: Hold
Price Target: $35.30
Current: $31.82
Upside: +10.94%
Shanghai Junshi Biosciences Co., Ltd.
Mar 13, 2026
Reiterated: Hold
Price Target: $34.70
Current: $19.30
Upside: +79.79%
InnoCare Pharma Limited
Dec 14, 2025
Reiterated: Buy
Price Target: $23.60
Current: $14.79
Upside: +59.57%
RemeGen Co., Ltd.
Dec 9, 2025
Reiterated: Hold
Price Target: $63.80
Current: $77.10
Upside: -17.25%
Hangzhou Tigermed Consulting Co., Ltd
Sep 1, 2025
Reiterated: Buy
Price Target: $50.00 → $56.30
Current: $46.88
Upside: n/a
Joinn Laboratories(China)Co.,Ltd.
Jul 14, 2025
Reiterated: Hold
Price Target: $14.30 → $16.30
Current: $30.80
Upside: n/a
WuXi AppTec Co., Ltd.
Nov 1, 2024
Upgraded: Buy
Price Target: $40.10 → $70.40
Current: $215.20
Upside: n/a
Shanghai MicroPort MedBot (Group) Co., Ltd.
Sep 11, 2024
Reiterated: Buy
Price Target: $20.00 → $9.50
Current: $21.18
Upside: n/a
Apr 23, 2024
Initiated Coverage: Buy
Price Target: $35.70
Current: $23.00
Upside: n/a
Feb 29, 2024
Reiterated: Buy
Price Target: $286
Current: $365.94
Upside: n/a
Nov 23, 2023
Initiated Coverage: Buy
Price Target: $123.10
Current: $487.00
Upside: n/a
Aug 30, 2021
Reiterated: Hold
Price Target: 223p
Current: 748p
Upside: n/a